Identification of risk factors associated with oral 5-aminolevulinic acid induced adverse events in photodynamic diagnosis−transurethral resection of bladder tumor-Reference-Cited by-同舟云学术

Identification of risk factors associated with oral 5-aminolevulinic acid induced adverse events in photodynamic diagnosis−transurethral resection of bladder tumor

Published:2024-10 Issue: Volume:49 Page:104291
ISSN:1572-1000
Container-title:Photodiagnosis and Photodynamic Therapy
language:en
Short-container-title:Photodiagnosis and Photodynamic Therapy

Author:

Okabe Yu^ORCID,Fukuhara Yuichiro,Matsuoka Wataru,Nakamura Nobuyuki,Matsuzaki Hiroshi,Miyazaki Takeshi,Gunge Naotaka,Tominaga Kosuke,Tsubouchi Kazuna,Tachibana Masahiro,Nakagawa Chizuru,Yamazaki Fumihiro,Haga Nobuhiro

Publisher

Elsevier BV

Reference27 articles.

1. Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer;Kobayashi;Photodiagnosis. Photodyn. Ther.,2023

2. Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non-muscle-invasive bladder cancer: a comparative study from experienced institutes;Miyake;BJUI Compass,,2023

3. Efficacy and safety of hexaminolevulinate fluorescence cystoscopy in the diagnosis of bladder cancer;Lee;Korean J. Urol.,2012

4. A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging;Lee;BMC. Cancer,2015

5. Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : a multicenter randomized, double-blind, placebo-controlled trial;Stenzl;Cancer,2011